Categorynews

Global Antihypertensive Drugs Market 2019-2023| Evolving Opportunities with AstraZeneca and Johnson & Johnson Services, Inc. | Technavio

November 19, 2019 Off By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global antihypertensive drugs market and the market is poised to grow by USD 3.96 billion during 2019-2023 at a CAGR of over 2% during the forecast period. Request Free Sample Pages

Read the 124-page research report with TOC on “Antihypertensive Drugs Market Analysis Report by Type (Systemic hypertension and Pulmonary hypertension), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 – 2023”.

The market is driven by the availability of a wide range of antihypertensive drugs. In addition, the development of modified-release formulations is anticipated to further boost the growth of the antihypertensive drugs market.

Physicians prescribe antihypertensive drugs for patients suffering from hypertension. These drugs are developed to minimize cardiac output by depressing stroke volume and heart rate. Some antihypertensive drugs reduce systemic vascular resistance or central venous pressure and cardiac output. Indapamide and polythiazide are some of the examples of these drugs. Thus, the availability of a wide range of drugs is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Antihypertensive Drugs Market Companies:

AstraZeneca

AstraZeneca is headquartered in the UK and operates under the business segment: Biopharmaceuticals. The company offers DUTOPROL, which is a metoprolol succinate extended-release or a hydrochlorothiazide.

Johnson & Johnson Services, Inc.

Johnson & Johnson Services, Inc. is headquartered in the US and offers products through the following business units: Consumer, Pharmaceutical, and Medical devices. The company offers OPSUMIT, TRACLEER, UPTRAVI, VELETRI, and VENTAVIS.

Merck & Co., Inc.

Merck & Co., Inc. is headquartered in the US operates under various business segments, namely Pharmaceutical and Other. The company offers COZAAR, HYZAAR, and PRINIVIL. In addition, the company caters to end-users such as hospitals and pharmacies.

Novartis AG

Novartis AG is headquartered in Switzerland and offers products through the following business segments: Innovative medicines, Sandoz, and Alcon. The company offers DIOVAN, DIOVAN HCT, ENTRESTO, EXFORGE HCT, and LOTREL.

Pfizer Inc.

Pfizer Inc. is headquartered in the US and offers products through the following business segments: Innovative health and Essential health. The company offers ACCURETIC, NORVASC, and REVATIO. They cater to end-users such as hospitals and pharmacies.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Antihypertensive Drugs Type Outlook (Revenue, USD Million, 2019 – 2023)

Systemic hypertension
Pulmonary hypertension

Antihypertensive Drugs Regional Outlook (Revenue, USD Million, 2019 – 2023)

Asia
Europe
North America
ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care are:

Pericarditis Drugs Market – Global Pericarditis Drugs Market by product (NSAIDs, colchicine, and others) and geography (Asia, Europe, North America, and ROW).

Pruritus Drugs Market – Global Pruritus Drugs Market by application (hematologic pruritus, oncological pruritus, renal pruritus, endocrine pruritus, and cholestatic pruritus), RoA (topical, oral, and parenteral) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.